Last Price
0.007
Today's Change
0.00 (0.00%)
Day's Change
0.007 - 0.007
Trading Volume
478,571
Market Cap
35 Million
Shares Outstanding
5 Billion
Avg Volume
7,800,270
Avg Price (50 Days)
0.01
Avg Price (200 Days)
0.01
PE Ratio
-0.70
EPS
-0.01
Earnings Announcement
26-Feb-2025
Previous Close
0.01
Open
0.01
Day's Range
0.007 - 0.007
Year Range
0.004 - 0.015
Trading Volume
478,571
1 Day Change
0.00%
5 Day Change
-12.50%
1 Month Change
0.00%
3 Month Change
-41.67%
6 Month Change
40.00%
Ytd Change
-17.65%
1 Year Change
-7.36%
3 Year Change
-76.92%
5 Year Change
-94.11%
10 Year Change
-88.52%
Max Change
-96.10%
No result.
Sector: Healthcare - Healthcare
Industry: Medical Devices
Description:
OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorporated in 2005 and is headquartered in North Sydney, Australia.